Citations

Citations to this article as recorded by  

• Regulation of Pain Perception by Microbiota in Parkinson Disease
  Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco, Habibeh Khoshbouei
  Pharmacological Reviews.2024; 76(1): 7.     CrossRef
• Emerging wearable technologies for multisystem monitoring and treatment of Parkinson’s disease: a narrative review
  Yasmine M. Kehnemouyi, Todd P. Coleman, Peter A. Tass
  Frontiers in Network Physiology.2024;[Epub]     CrossRef
• N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis
  Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang
  Brain Research Bulletin.2023; 202: 110729.     CrossRef
• Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
  Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi
  Anesthesiology and Pain Medicine.2023;[Epub]     CrossRef
• Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
  Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi
  CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008.     CrossRef
• A look back at the prodromal findings in Parkinson’s disease
  Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
  Bulletin of the National Research Centre.2023;[Epub]     CrossRef
• Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
  Xuxiang Zhang, Beisha Tang, Jifeng Guo
  Translational Neurodegeneration.2023;[Epub]     CrossRef
• Association between malnutrition and motor/non-motor symptoms in elderly with Parkinson disease
  Heewon Bae, Sang-Won Ha
  Journal of Geriatric Neurology.2023; 2(2): 58.     CrossRef
• Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life
  Nir Bar, Amel Karaa, Katheryn Kiser, Braden Kuo, Claire Zar-Kessler
  Clinical and Translational Gastroenterology.2023; 14(12): e00633.     CrossRef
• Nutritional aspects in Parkinson’s disease
  Paulina Gątarek, Joanna Kałużna-Czaplińska
  Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467.     CrossRef
• Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
  Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
  Nutrients.2022; 14(2): 380.     CrossRef
• Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
  Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang
  Frontiers in Neurology.2022;[Epub]     CrossRef
• Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
  Tong Guo, Li Chen
  European Journal of Inflammation.2022; 20: 1721727X2210837.     CrossRef
• Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
  Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal
  Folia Microbiologica.2022; 67(5): 693.     CrossRef
• Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
  Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi
  Journal of Molecular Neuroscience.2022; 72(9): 1952.     CrossRef
• Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
  Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
  Frontiers in Neurology.2022;[Epub]     CrossRef
• The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
  Yasir Bashir, Asad U. Khan
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
  Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun
  Microbial Pathogenesis.2021; 150: 104675.     CrossRef
• Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
  Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
  Acta Pharmaceutica Sinica B.2021;[Epub]     CrossRef
• Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
  Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl
  International Journal of Molecular Sciences.2021; 22(6): 3233.     CrossRef
• Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
  Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye
  Neurochemical Research.2021; 46(11): 3050.     CrossRef
• ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
  Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness
  Journal of Parkinson's Disease.2021; 11(4): 1821.     CrossRef
• The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
  Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
  Pharmacological Research.2021; 172: 105840.     CrossRef
• Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
  Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee
  Brain, Behavior, and Immunity.2021; 98: 357.     CrossRef
• Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
  Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau
  Neurotoxicity Research.2021; 39(6): 2141.     CrossRef
• Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
  Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang
  Microbiome.2021;[Epub]     CrossRef
• Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease
  Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness
  Neurogastroenterology & Motility.2020;[Epub]     CrossRef
• Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
  Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa
  European Journal of Pharmaceutical Sciences.2020; 147: 105280.     CrossRef
• Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa
  Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano
  Revista Brasileira de Geriatria e Gerontologia.2020;[Epub]     CrossRef
• Probiotics for Parkinson’s Disease
  Gazerani
  International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
• Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
  Eliseu da Cruz Moreira-Junior
  Medical Hypotheses.2019; 133: 109399.     CrossRef
• Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
  Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao
  Current Neurovascular Research.2019; 16(3): 241.     CrossRef
• α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon
  M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong
  Neuroscience.2019; 423: 76.     CrossRef
• Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
  Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen
  Brain, Behavior, and Immunity.2018; 70: 48.     CrossRef
• Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
  Meng-Fei Sun, Yan-Qin Shen
  Ageing Research Reviews.2018; 45: 53.     CrossRef
• Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
  Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
  British Journal of Clinical Pharmacology.2018; 84(11): 2551.     CrossRef
• Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial
  Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab
  Clinical Neuropharmacology.2018; 41(5): 151.     CrossRef
• Role of Microbiota in Neurodegenerative Diseases
  C. V. Sobol
  Russian Journal of Developmental Biology.2018; 49(6): 297.     CrossRef
• α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
  Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
  Neurological Sciences.2017; 38(1): 171.     CrossRef
• Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
  Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
  Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
• Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
  Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim
  Expert Review of Neurotherapeutics.2017; 17(7): 737.     CrossRef
• Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
  Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu
  Brain Research.2016; 1642: 180.     CrossRef
• Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
  Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi
  Parkinsonism & Related Disorders.2016;[Epub]     CrossRef
• An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient
  Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park
  Korean Journal of Spine.2015; 12(3): 153.     CrossRef

Citations

Citations to this article as recorded by  

• Neuroimmune Connectomes in the Gut and Their Implications in Parkinson’s Disease
  Beatriz Thomasi, Luisa Valdetaro, Brian Gulbransen, Ana Lúcia Tavares-Gomes
  Molecular Neurobiology.2024; 61(4): 2081.     CrossRef
• Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial
  Lingyu Wu, Liwen Chu, Hongdou Cao, Qi Tian, Hua Gao, Jinghong Huo, Qinghan Gao
  Food Bioscience.2024; 57: 103548.     CrossRef
• The missing piece of the puzzle – The key role of the dietitian in the management of Parkinson's disease
  Richelle Flanagan, Carley Rusch, Fiona E. Lithander, Indu Subramanian
  Parkinsonism & Related Disorders.2024; 121: 106021.     CrossRef
• Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease
  Xianwei Zou, Xiaqing Chen, Yanxia Wen, Xiaofeng Jing, Man Luo, Fengyue Xin, Yao Tang, Mengfei Hu, Jian Liu, Fan Xu
  Frontiers in Neurology.2024;[Epub]     CrossRef
• Persistent intolerable abdominal pain in patients with Parkinson’s disease
  Hiroshi Kataoka, Kazuma Sugie
  Clinical Neurology and Neurosurgery.2023; 224: 107558.     CrossRef
• Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
  Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim
  Clinical Nuclear Medicine.2023; 48(2): 143.     CrossRef
• The gut microbiota is an emerging target for improving brain health during ageing
  Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox
  Gut Microbiome.2023;[Epub]     CrossRef
• 6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease
  Maria Del Pilar Murillo, Ebba Johansson, Victoria Bryntesson, Patrik Aronsson, Gunnar Tobin, Michael Winder, Thomas Carlsson, Stephen Fink
  Gastroenterology Research and Practice.2023; 2023: 1.     CrossRef
• Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial
  Ying-Jia Li, Ian-I Leong, Jing-Qi Fan, Ming-Yue Yan, Xin Liu, Wei-Jing Lu, Yuan-Yuan Chen, Wei-Qiang Tan, Yu-Ting Wang, Li-Xing Zhuang
  Frontiers in Neuroscience.2023;[Epub]     CrossRef
• Considerations for developing a targeted amino acid supplement for people with Parkinson’s disease that promotes health while accounting for pathophysiology and medication interference
  Jacob E Earp, Cristina Colon-Semenza, Dara L LoBuono
  Nutrition Reviews.2023; 81(8): 1063.     CrossRef
• Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis
  Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen, Fengwei Tian
  Nutrients.2023; 15(7): 1737.     CrossRef
• The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study
  Charlotte B. Stewart, David Ledingham, Victoria K. Foster, Kirstie N. Anderson, Sahana Sathyanarayana, Debra Galley, Nicola Pavese, Jacopo Pasquini
  Frontiers in Neurology.2023;[Epub]     CrossRef
• Association of dysphagia with altered brain glucose metabolism in Parkinson's disease
  Ji Yeon Oh, Eui Jin An, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim
  CNS Neuroscience & Therapeutics.2023; 29(9): 2498.     CrossRef
• Differential Findings on Anorectal Manometry in Patients with Parkinson's Disease and Defecatory Dysfunction
  Wendy Zhou, George Triadafilopoulos, Brooke Gurland, Houssam Halawi, Laren Becker, Patricia Garcia, Linda Nguyen, Mitchell Miglis, Srikanth Muppidi, Dong‐In Sinn, Safwan Jaradeh, Leila Neshatian
  Movement Disorders Clinical Practice.2023; 10(7): 1074.     CrossRef
• Abdominal pain in Parkinson’s disease
  A.A. Pilipovich, O.V. Vorobyova, S.A. Makarov
  Russian Journal of Pain.2023; 21(2): 12.     CrossRef
• Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
  Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo
  CNS & Neurological Disorders - Drug Targets.2023; 22(9): 1355.     CrossRef
• Constipation in Parkinson's Disease
  Eamonn M. M. Quigley
  Seminars in Neurology.2023; 43(04): 562.     CrossRef
• Autonomic symptoms in early-stage Parkinson’s patients and their relationship with cognition and disease parameters
  Esma KOBAK TUR, Eren GÖZKE
  Anatolian Current Medical Journal.2023; 5(4): 498.     CrossRef
• Lower gastrointestinal dysfunction in patients with Parkinson’s disease
  A.A. Pilipovich, O.V. Vorob’eva, S.A. Makarov, A.V. Kuchuk
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2023; 123(12): 42.     CrossRef
• Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis
  Yuansen Li, Deshenyue Kong, Ke Bi, Huayou Luo
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum
  Alexandra D. Zinnen, Jonathan Vichich, Jeanette M. Metzger, Julia C. Gambardella, Viktoriya Bondarenko, Heather A. Simmons, Marina E. Emborg, Stephan N. Witt
  PLOS ONE.2022; 17(6): e0269190.     CrossRef
• Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
  Roongroj Bhidayasiri, Warongporn Phuenpathom, Ai Huey Tan, Valentina Leta, Saisamorn Phumphid, K. Ray Chaudhuri, Pramod Kumar Pal
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches
  E.A. Katunina, N.N. Shipilova, D.A. Katunin
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(8): 21.     CrossRef
• Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
  Huijia Yang, Song Li, Weidong Le
  Aging and disease.2022; 13(5): 1381.     CrossRef
• The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
  Yasir Bashir, Asad U. Khan
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease
  Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao
  World Journal of Gastrointestinal Pharmacology and Therapeutics.2021; 12(1): 21.     CrossRef
• Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort
  Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Alfred Chin Yen Tay, Samantha Winter, Frank L. Mastaglia, Ryan S. Anderton
  Movement Disorders Clinical Practice.2021; 8(2): 245.     CrossRef
• Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat
  Cynthia Kwan, Imane Frouni, Dominique Bédard, Adjia Hamadjida, Philippe Huot
  Behavioural Pharmacology.2021; 32(1): 43.     CrossRef
• Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status
  Luciana Grolli Ardenghi, Alana Verza Signorini, Gerson Schulz Maahs, Fabio Selaimen, Konrado Massing Deutsch, Silvia Dornelles, Carlos Roberto de Mello Rieder
  International Archives of Otorhinolaryngology.2021; 25(01): e41.     CrossRef
• Spectrum of Non-Motor Symptoms in Parkinson's Disease
  Maithrayie Kumaresan, Safeera Khan
  Cureus.2021;[Epub]     CrossRef
• Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans
  Gregory D. Scott, Miranda M. Lim, Matthew G. Drake, Randy Woltjer, Joseph F. Quinn
  Movement Disorders.2021; 36(9): 2094.     CrossRef
• The Gastrointestinal Dysfunction Scale for Parkinson's Disease
  Marta Camacho, Julia C. Greenland, Caroline H. Williams‐Gray
  Movement Disorders.2021; 36(10): 2358.     CrossRef
• The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
  Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
  Pharmacological Research.2021; 172: 105840.     CrossRef
• Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
  Katiane Roversi, Natalia Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment
  Zhichun Chen, Guanglu Li, Jun Liu
  Neurobiology of Disease.2020; 134: 104700.     CrossRef
• Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
  Ji‐Hyun Choi, Jee‐Young Lee, Jin Whan Cho, Seong‐Beom Koh, Young Soon Yang, Dalla Yoo, Cheol‐Min Shin, Hee Tae Kim
  Movement Disorders.2020; 35(11): 1966.     CrossRef
• Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
  R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri
  Nature Reviews Gastroenterology & Hepatology.2020; 17(11): 673.     CrossRef
• Expanding the brain researcher's toolkit
  Viviana Gradinaru
  Science.2020; 369(6504): 637.     CrossRef
• Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
  Olivier Rascol, Laurence Negre-Pages, Philippe Damier, Arnaud Delval, Pascal Derkinderen, Alain Destée, Margherita Fabbri, Wassilios G. Meissner, Amine Rachdi, François Tison, Santiago Perez-Lloret
  Journal of Neural Transmission.2020; 127(12): 1607.     CrossRef
• Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom
  Peter Urban, Bjorn Falkenburger, Wolfgang H. Jost, Gerhard Ransmayr, Peter Riederer, Christian Winkler
  Fortschritte der Neurologie · Psychiatrie.2020; 88(09): 591.     CrossRef
• Parkinson’s disease: Are gut microbes involved?
  Yogesh Bhattarai, Purna C. Kashyap
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 319(5): G529.     CrossRef
• Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson’s Disease? Results of a Randomized Cross-Over Study
  Guillaume Gourcerol, David Maltete, Nathalie Chastan, Marie Laure Welter, Anne Marie Leroi, Stéphane Derrey
  Neuromodulation: Technology at the Neural Interface.2019; 22(4): 478.     CrossRef
• Probiotics for Parkinson’s Disease
  Gazerani
  International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
• Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats
  Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch
  PLOS ONE.2018; 13(1): e0190078.     CrossRef
• Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
  Fredric P. Manfredsson, Kelvin C. Luk, Matthew J. Benskey, Aysegul Gezer, Joanna Garcia, Nathan C. Kuhn, Ivette M. Sandoval, Joseph R. Patterson, Alana O'Mara, Reid Yonkers, Jeffrey H. Kordower
  Neurobiology of Disease.2018; 112: 106.     CrossRef
• Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
  Meng-Fei Sun, Yan-Qin Shen
  Ageing Research Reviews.2018; 45: 53.     CrossRef
• Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects
  Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree
  Current Treatment Options in Gastroenterology.2018; 16(4): 489.     CrossRef
• Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
  Takashi Ogawa, Genko Oyama, Nobutaka Hattori
  BMJ Case Reports.2018; : bcr-2017-223722.     CrossRef
• α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
  Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
  Neurological Sciences.2017; 38(1): 171.     CrossRef
• The Threshold Theory for Parkinson's Disease
  Simone Engelender, Ole Isacson
  Trends in Neurosciences.2017; 40(1): 4.     CrossRef
• Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives
  Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer
  Movement Disorders.2017; 32(1): 94.     CrossRef
• Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
  Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar
  Advances in Parkinson's Disease.2017; 06(01): 1.     CrossRef
• Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
  Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
  Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
• Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis
  C.-H. Chen, C.-L. Lin, C.-H. Kao
  Osteoporosis International.2016; 27(6): 2117.     CrossRef
• Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
  Syed Ali, Ning Yin, Arkam Rehman, Verline Justilien
  Medical Sciences.2016; 4(1): 1.     CrossRef
• Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models
  C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, M. Fornai
  Neurogastroenterology & Motility.2016; 28(12): 1781.     CrossRef
• Gut dysfunction in Parkinson's disease
  Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das
  World Journal of Gastroenterology.2016; 22(25): 5742.     CrossRef
• Inflammation is genetically implicated in Parkinson’s disease
  N. Dzamko, C.L Geczy, G.M Halliday
  Neuroscience.2015; 302: 89.     CrossRef
• Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson’s disease rats
  Xiaoli Zhang, Yun Li, Chenzhe Liu, Ruifang Fan, Ping Wang, Lifei Zheng, Feng Hong, Xiaoyan Feng, Yue Zhang, Lisheng Li, Jinxia Zhu
  Translational Research.2015;[Epub]     CrossRef
• The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
  Jose L Barboza, Michael S Okun, Baharak Moshiree
  Expert Opinion on Pharmacotherapy.2015; 16(16): 2449.     CrossRef
• Gastrointestinal Dysfunctions in Parkinson’s Disease
  Joong-Seok Kim, Hey Young Sung
  Journal of the Korean Neurological Association.2015; 33(4): 247.     CrossRef